Menu
Recruiting NCT07075068

The Effects of Cigarette Addiction on Lower Extremity Movement Speed and Coordination

— Observational Smoking Cessation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Behavioral and Functional Performance Assessment Battery.
Who it may be relevant to
Registry conditions: Smoking Cessation. Basic parameters: 18 years — 25 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

The Effects of Cigarette Addiction on Lower Extremity Movement Speed and Coordination in Young Adults

Overview

This observational study will aim to investigate the effects of cigarette addiction on lower extremity motor coordination and movement speed in young adults. The study will include healthy participants aged 18-25 years, divided into smokers and non-smokers. Motor coordination will be assessed using the Lower Extremity Motor Coordination Test (LEMOCOT), and speed will be evaluated with a 30-meter sprint test. Nicotine dependence will be evaluated in smokers using the Fagerström Test. The findings will provide insight into the possible functional impacts of nicotine addiction on motor performance.

Detailed description

The study will be conducted as a non-randomized controlled observational trial at the Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation. A total of 24 healthy young adults (12 smokers, 12 non-smokers) will participate. The inclusion criteria will require participants to be aged 18-25, cooperative, literate, and able to walk independently. Participants will be categorized as smokers based on WHO and DSM-IV-TR criteria. The primary assessments will include LEMOCOT and 30-meter sprint test. Nicotine addiction will be measured using the Fagerström Test for Nicotine Dependence (FTND), and anthropometric data including BMI and bimalleolar diameter will also be recorded. Data will be analyzed to determine any statistical differences or correlations between smoking status and motor performance outcomes.

Interventions

  • Diagnostic test Behavioral and Functional Performance Assessment Battery
    This study will include only observational functional assessments. No active intervention will be performed.This observational protocol will involve standardized assessments of lower extremity coordination (LEMOCOT), movement speed (30-meter sprint), and smoking-related behavioral patterns (Fagerström Test for Nicotine Dependence). These tools will be used to evaluate the potential impact of cigarette addiction on physical performance in young adults. No therapeutic or pharmacological interventi

Primary outcome measures

  • LEMOCOT Score (Lower Extremity Motor Coordination Test) [Time frame: Baseline]
  • 30-Meter Sprint Time [Time frame: Baseline]
Secondary outcome measures (3)
  • Fagerström Test for Nicotine Dependence Score [Time frame: Baseline]
  • Body Mass Index (BMI) [Time frame: Baseline]
  • Bimalleolar Circumference and Diameter Measurement [Time frame: Baseline]

Eligibility criteria

Inclusion Criteria (for both groups):

  • Age between 18 and 25 years
  • Able to walk independently
  • Literate and cooperative
  • Willing to participate voluntarily
  • BMI between 18.5 and 29.9 kg/m²

Additional inclusion for smokers:

  • Daily smoking for at least one year based on WHO and DSM-IV-TR definitions
  • Exclusion Criteria (for all participants):
  • Orthopedic, neurologic, or neuromuscular disorders affecting gait
  • Chronic cardiopulmonary disease
  • Cognitive impairments
  • Obesity (BMI ≥ 30 kg/m²)

Additional exclusion for smokers:

  • History of acute cardiovascular events
  • Chronic heart failure or lung diseases

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Case-control

Study locations

Turkey (Türkiye) · 1 center
  • Esra Pehlivan — Istanbul

Identifiers

NCT: NCT07075068 · Smoking&Speed

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗